Records 1 - 30
| Age does matter in adolescents and young adults vs. older adults with lung adenocarcinoma: A retrospective analysis comparing clinical characteristics and outcomes in response to systematic treatments.
Oncology letters 2022 Oct 24 (4): 362.
Zhou Lin, Li Huiwu, Yang Shuh
| Differentiating EGFR from ALK mutation status using radiomics signature based on MR sequences of brain metastasis.
European journal of radiology 2022 Oct 155 110499.
Li Ye, Lv Xinna, Wang Bing, Xu Zexuan, Wang Yichuan, Gao Shan, Hou Dail
| Genotyping of cerebrospinal fluid in lung cancer patients with leptomeningeal metastasis.
Thoracic cancer 2022 Sep 13 (18): 2574-2583.
Nie Naifu, Zhou Haodong, Zhang Kejun, Liu Lan, Luo Nuo, Wang Renyuan, Li Xin, Zhu Mengxiao, Hu Chen, Wang Yubo, Liu Zhulin, Li Li, He Yo
| Advances in the treatment of postoperative recurrence of non-small cell lung cancer and their impact on survival in Asian patients.
The Journal of thoracic and cardiovascular surgery 2022 Aug .
Hashimoto Kohei, Ariyasu Ryo, Ichinose Junji, Matsuura Yosuke, Nakao Masayuki, Amino Yoshiaki, Uchibori Ken, Kitazono Satoru, Yanagitani Noriko, Okumura Sakae, Nishio Makoto, Mun Mingy
| CKAP2 overexpression correlates with worse overall survival in patients with lung adenocarcinoma.
Medicine 2022 Jul 101 (30): e29796.
Zhang Sen, Li Na, Yang Yonghua, Li Yan, Lin Chenshi, Fu Guoquan, Cai J
| Efficacy and safety of lorlatinib in Asian and non-Asian patients with ALK-positive advanced non-small cell lung cancer: Subgroup analysis of a global phase 2 trial.
Lung cancer (Amsterdam, Netherlands) 2022 Jul 169 67-76.
Soo Ross A, Huat Tan Eng, Hayashi Hidetoshi, Seto Takashi, Lin Chia-Chi, Ignatius Ou Sai-Hong, Kim Dong-Wan, Liu Geoffrey, Abbattista Antonello, Martini Jean-François, Hooi Wong Chew, Toffalorio Francesca, Solomon Benjamin
| Computed tomography-guided lung biopsy for molecular tests: a meta-analysis.
Kardiochirurgia i torakochirurgia polska = Polish journal of cardio-thoracic surgery 2022 Jun 19 (2): 96-101.
Zhang Jian-Hua, Xia Feng-Fei, Yang Xiao-Shan, Li
| Differential prognostic effect of systemic inflammation in patients with non-small cell lung cancer treated with immunotherapy or chemotherapy: A post hoc analysis of the phase 3 OAK trial.
Cancer 2022 Jun .
Cortellini Alessio, Ricciuti Biagio, Borghaei Hossein, Naqash Abdul Rafeh, D'Alessio Antonio, Fulgenzi Claudia A M, Addeo Alfredo, Banna Giuseppe L, Pinato David Jam
| Circulating Tumor DNA-Based Genotyping and Monitoring for Predicting Disease Relapses of Patients with Peripheral T-Cell Lymphomas.
Cancer research and treatment 2022 Mar .
Kim Seok Jin, Kim Yeon Jeong, Yoon Sang Eun, Ryu Kyung Ju, Park Bon, Park Donghyun, Cho Duck, Kim Hyun-Young, Cho Junhun, Ko Young Hyeh, Park Woong-Yang, Kim Won Se
| ALK fusion variant 3a/b, concomitant mutations, and high PD-L1 expression were associated with unfavorable clinical response to second-generation ALK TKIs in patients with advanced ALK-rearranged non-small cell lung cancer (GASTO 1061).
Lung cancer (Amsterdam, Netherlands) 2022 Jan 165 54-62.
Li Meichen, Hou Xue, Chen Jing, Zhang Baishen, Wang Na, Han Hongyu, Chen Lik
| Clinical characteristics of non-small cell lung cancer patients with EGFR mutations and ALK&ROS1 fusions.
The clinical respiratory journal 2022 Jan .
Liu Qinghua, Huang Qingyan, Yu Zhikang, Wu Hemi
| Correlation between Programmed Death Ligand-1(PD-L1) Expression and Driver Gene Mutations in Non-Small Cell Lung Carcinoma- Adenocarcinoma Phenotype.
Asian Pacific journal of cancer prevention : APJCP 2022 Jan 23 (1): 131-142.
Pandey Rahul Kumar, Shukla Saumya, Husain Nuzhat, Islam Mohammad Hayatul, Hadi Rahat, Kant Tripathi Surya, Singhal Ashi
| A Somatic Mutation Signature Predicts the Best Overall Response to Anti-programmed Cell Death Protein-1 Treatment in Epidermal Growth Factor Receptor/Anaplastic Lymphoma Kinase-Negative Non-squamous Non-small Cell Lung Cancer.
Frontiers in medicine 2022 9 808378.
Peng Jie, Xiao Lushan, Zou Dan, Han Lij
| Estimating survival and clinical outcome in advanced non-small cell lung cancer with bone-only metastasis using molecular markers.
Journal of bone oncology 2021 Dec 31 100394.
Meng Chunliu, Wei Jia, Tian Jia, Ma Jintao, Liu Ningbo, Yuan Zhiyong, Zhao Lujun, Wang Pi
| Outcomes of Gamma Knife Radiosurgery for Brain Metastases From Anaplastic Lymphoma Kinase Rearrangement-Positive and EGFR Mutation-Positive Non-Small Cell Lung Cancer.
Cureus 2021 Dec 13 (12): e20398.
Matsunaga Shigeo, Shuto Takas
| Integration of clinicopathological and mutational data offers insight into lung cancer with tumor spread through air spaces.
Annals of translational medicine 2021 Jun 9 (12): 985.
Tian Yu, Feng Jing, Jiang Long, Ning Junwei, Gu Zenan, Huang Jia, Luo Qingqu
| NGS-based liquid biopsy profiling identifies mechanisms of resistance to ALK inhibitors: a step toward personalized NSCLC treatment.
Molecular oncology 2021 May .
Sánchez-Herrero Estela, Serna-Blasco Roberto, Ivanchuk Vadym, García-Campelo Rosario, Dómine Gómez Manuel, Miguel Sánchez José, Massutí Bartomeu, Reguart Noemi, Camps Carlos, Sanz-Moreno Sandra, Calabuig-Fariñas Silvia, Jantus-Lewintre Eloísa, Arnal Magdalena, Fernández-Orth Dietmar, Calvo Virginia, González-Rumayor Víctor, Provencio Mariano, Romero Atoc
| ALK-Negative Anaplastic Large Cell Lymphoma (ALCL): Prognostic Implications of Molecular Subtyping and JAK-STAT Pathway.
Applied immunohistochemistry & molecular morphology : AIMM 2021 Apr .
Parkhi Mayur, Bal Amanjit, Das Ashim, Kashyap Dharambir, Bhardwaj Sandeep, Prakash Gaurav, Malhotra Pank
| Preoperative nivolumab to evaluate pathological response in patients with stage I non-small cell lung cancer: a study protocol of phase II trial (POTENTIAL).
BMJ open 2021 (3): e043234.
Kagimoto Atsushi, Tsutani Yasuhiro, Mimae Takahiro, Miyata Yoshihiro, Ikeda Norihiko, Ito Hiroyuki, Maniwa Yoshimasa, Suzuki Kenji, Tsuboi Masahiro, Yoshimura Kenichi, Umemoto Seiji, Okada Morihi
| Value of CT features for predicting EGFR mutations and ALK positivity in patients with lung adenocarcinoma.
Scientific reports 2021 Mar 11 (1): 5679.
Han Xiaoyu, Fan Jun, Li Yumin, Cao Yukun, Gu Jin, Jia Xi, Wang Yuhui, Shi Hesh
| A population-based study of outcomes in patients with surgically resected non-small cell lung cancer with anaplastic lymphoma kinase-rearranged mutations: A matched-pair study.
Molecular and clinical oncology 2021 Jan 14 (1): 11.
Inagaki Masaharu, Ichimura Hideo, Usui Shingo, Iguchi Kesato, Ishibashi Osamu, Nakamura Ryota, Inage Yoshihisa, Suzuki Hisashi, Kiyoshima Moriyuki, Kamiyama Koichi, Kimura Masaki, Yoshida Susumu, Sakai Mitsuaki, Kobayashi Naohiro, Furukawa Kinya, Satoh Hiroaki, Hizawa Nobuyuki, Sato Yuk
| SMARCA4/BRG1-Deficient Non-Small Cell Lung Carcinomas: A Case Series and Review of the Literature.
Archives of pathology & laboratory medicine 2021 Jan 145 (1): 90-98.
Nambirajan Aruna, Singh Varsha, Bhardwaj Nishu, Mittal Saurabh, Kumar Sunil, Jain Deepa
| Molecular characterization of lung carcinomas: A study on diagnostic, predictive, and prognostic markers using immunohistochemical analysis at a Tertiary Care Center in Uttarakhand, India.
Journal of carcinogenesis 2021 20 17.
Rao Shalinee, Anthony Michael Leonard, Chowdhury Nilotpal, Kathrotia Rajesh, Mishra Mayank, Naithani Manisha, Sindhwani Girish, Singh Ne
| Multiple combination therapy based on intrathecal pemetrexed in non-small cell lung cancer patients with refractory leptomeningeal metastasis.
Annals of palliative medicine 2020 Nov 9 (6): 4233-4245.
Miao Qian, Zheng Xiaobin, Zhang Longfeng, Jiang Kan, Wu Biao, Lin G
| Differentiating synchronous double primary lung adenocarcinomas from intrapulmonary metastasis by CT features, EGFR mutations and ALK rearrangement status.
Journal of thoracic disease 2020 Oct 12 (10): 5505-5516.
Han Xiaoyu, Fan Jun, Liu Tong, Li Na, Alwalid Osamah, Gu Jin, Shi Hesh
| Driver gene alterations in lung adenocarcinoma: Demographic features of 2544 Chinese cases.
The International journal of biological markers 2020 Oct 1724600820967015.
Hu Mingming, Zhang Tongmei, Yang Yuan, Che Nanying, Li Jie, Liu Zichen, Li Baol
| CT features associated with EGFR mutations and ALK positivity in patients with multiple primary lung adenocarcinomas.
Cancer imaging : the official publication of the International Cancer Imaging Society 2020 Jul 20 (1): 51.
Han Xiaoyu, Fan Jun, Gu Jin, Li Yumin, Yang Ming, Liu Tong, Li Nan, Zeng Wenjuan, Shi Hesh
| Effect of Asbestos Exposure on the Frequency of EGFR Mutations and ALK/ROS1 Rearrangements in Patients With Lung Adenocarcinoma: A Multicentric Study.
Journal of occupational and environmental medicine 2020 Jan Publish Ahead of Print .
Yilmaz Senay, Demirci Nilgun Yilmaz, Metintas Selma, Zamani Adil, Karadag Mehmet, Guçlu Ozge A, Kabalak Pinar Akin, Yilmaz Ul
| ALK variants, PD-L1 expression, and their association with outcomes in ALK-positive NSCLC patients.
Scientific reports 2020 12 10 (1): 21063.
Chang Gee-Chen, Yang Tsung-Ying, Chen Kun-Chieh, Hsu Kuo-Hsuan, Huang Yen-Hsiang, Su Kang-Yi, Yu Sung-Liang, Tseng Jeng-S
| The Genomic Characteristics of ALK Fusion Positive Tumors in Chinese NSCLC Patients.
Frontiers in oncology 2020 10 726.
Liu Shaokun, Huang Tanxiao, Liu Ming, He Wenlong, Zhao YingShen, Yang Lizhen, Long Yingjiao, Zong Dandan, Zeng Huihui, Liu Yuanyuan, Liao Wenting, Duan Jingxian, Gong Subo, Chen Shi